Promoter Jay Arvind Bhanushali Acquires Additional Stake in Aspira Pathlab & Diagnostics
Aspira Pathlab & Diagnostics Ltd 路 Acquisition/ Disposal of Shares 路 14 Nov 2026, 4:27 pm
Promoter Jay Arvind Bhanushali Acquires Additional Stake in Aspira Pathlab & Diagnostics Promoter Jay Arvind Bhanushali acquired 1,599 equity shares (0.015% / ~0.02% stake) of Aspira Pathlab & Diagnostics Ltd via an open-market transaction on 13th Nov'26. Prior to this purchase, Bhanushali held 7,50,796 shares, representing 7.29% of the company's total voting capital. Following the acquisition, the promoter's total holding increased to 7,52,395 equity shares, elevating the overall equity and diluted voting stake to 7.31%. Total equity share capital remains unchanged at Rs 10.29 cr, comprising 1,02,93,000 equity shares of Rs 10 each.
Original exchange filing (PDF)
More announcements from Aspira Pathlab & Diagnostics Ltd
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 18 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 14 Nov 2026
- Enclosed herewith Financial Result for the Half Year ended 30th September 2026 路 06 Nov 2026
- Enclosed herewith Board Meeting Outcomes dated 6th November 2026 路 06 Nov 2026
- Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial .... 路 06 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 01 Oct 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 路 28 Sept 2026
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report 路 26 Sept 2026
